Salvage Cryoablation Safe, Effective for Recurrent Prostate Cancer After Radiotherapy
Salvage targeted cryoablation of the prostate (TCAP) is safe and effective for treating localized prostate cancer recurrence following radiotherapy, according to researchers in the
Investigators at the
The researchers observed no operative or cancer-related deaths during a mean follow-up of 33.5 months. The five-year actuarial biochemical recurrence-free survival for the high-, intermediate-, and low-risk groups was 11%, 45%, and 73%, respectively.
With respect to complications, 86% of patients experienced erectile dysfunction, 16% had lower urinary tract symptoms, and 13% had incontinence.
Findings appear in BJU International (2007;100:760-764).